SlideShare ist ein Scribd-Unternehmen logo
1 von 42
Cardiac Drug Sherry L. Knowles, RN, CCRN, CRNI Classifications
Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs Drug actions   Chronotropic     Dromotropic
[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],Cardiac Drugs D opa   receptors     Beta   receptors
[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs Heparin Low Molecular Weight Heparin Can be given on fix-dosed schedule and do not require APTT monitoring Less likely to cause thrombocytopenia Warfarin – Coumadin Rat poison Antagonist of vitamin K – blocks synthesis of vitamin K dependent  factors in coagulation cascade Peak effects take several days Antiplatelets
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs Streptokinase tPA
[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Cardiac Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],Cardiac Drugs

Weitere ähnliche Inhalte

Was ist angesagt?

Heart Failure- Clinical Therapeutics
Heart Failure- Clinical TherapeuticsHeart Failure- Clinical Therapeutics
Heart Failure- Clinical TherapeuticsTimothy Zagada
 
Antihypertensive drug part 1
Antihypertensive drug part 1 Antihypertensive drug part 1
Antihypertensive drug part 1 dr nainika sharma
 
Pharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailurePharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailureDr. Ashutosh Tiwari
 
Positive inotropic (ahmed salah)
Positive inotropic (ahmed salah)Positive inotropic (ahmed salah)
Positive inotropic (ahmed salah)Ahmed Salah
 
Anti hypertensive drugs Biomedical science slideshare
Anti hypertensive drugs Biomedical science slideshareAnti hypertensive drugs Biomedical science slideshare
Anti hypertensive drugs Biomedical science slideshareJersitaSherley
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugsajaykumarbp
 
Drug therapy of congestive heart failure
Drug therapy of congestive heart failureDrug therapy of congestive heart failure
Drug therapy of congestive heart failureDr Htet
 
Chronic heart failure
Chronic heart failure Chronic heart failure
Chronic heart failure Raniya Khalid
 
anti hypertensive drugs for nursing students
anti hypertensive drugs for nursing studentsanti hypertensive drugs for nursing students
anti hypertensive drugs for nursing studentsPatel Dharmendra
 
Drugs affecting cardiovascular system
Drugs affecting cardiovascular systemDrugs affecting cardiovascular system
Drugs affecting cardiovascular systemDina Ghoraba
 

Was ist angesagt? (20)

Heart Failure- Clinical Therapeutics
Heart Failure- Clinical TherapeuticsHeart Failure- Clinical Therapeutics
Heart Failure- Clinical Therapeutics
 
Week 5 Pharma
Week 5 PharmaWeek 5 Pharma
Week 5 Pharma
 
Antihypertensive drug part 1
Antihypertensive drug part 1 Antihypertensive drug part 1
Antihypertensive drug part 1
 
Pharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailurePharmacotherapy of Heart Failure
Pharmacotherapy of Heart Failure
 
Positive inotropic (ahmed salah)
Positive inotropic (ahmed salah)Positive inotropic (ahmed salah)
Positive inotropic (ahmed salah)
 
Anti hypertensive drugs Biomedical science slideshare
Anti hypertensive drugs Biomedical science slideshareAnti hypertensive drugs Biomedical science slideshare
Anti hypertensive drugs Biomedical science slideshare
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
 
worlb bank
worlb bankworlb bank
worlb bank
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Drug therapy of congestive heart failure
Drug therapy of congestive heart failureDrug therapy of congestive heart failure
Drug therapy of congestive heart failure
 
ACE Inhibitors & ARBs
ACE Inhibitors & ARBsACE Inhibitors & ARBs
ACE Inhibitors & ARBs
 
L19b. antihypertension
L19b. antihypertensionL19b. antihypertension
L19b. antihypertension
 
Chronic heart failure
Chronic heart failure Chronic heart failure
Chronic heart failure
 
anti hypertensive drugs for nursing students
anti hypertensive drugs for nursing studentsanti hypertensive drugs for nursing students
anti hypertensive drugs for nursing students
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
antihypertensive drugs
antihypertensive drugsantihypertensive drugs
antihypertensive drugs
 
Are all sartans equal
Are all sartans equalAre all sartans equal
Are all sartans equal
 
Congestive heart faillure
Congestive heart faillureCongestive heart faillure
Congestive heart faillure
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Drugs affecting cardiovascular system
Drugs affecting cardiovascular systemDrugs affecting cardiovascular system
Drugs affecting cardiovascular system
 

Ähnlich wie Drug Classifications

NurseReview.Org - Antihypertensives Updates (pharmacology review notes)
NurseReview.Org - Antihypertensives Updates (pharmacology review notes)NurseReview.Org - Antihypertensives Updates (pharmacology review notes)
NurseReview.Org - Antihypertensives Updates (pharmacology review notes)jben501
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensivesraj kumar
 
Antihypertensives | Classes of Drugs | Baro Receptor
Antihypertensives | Classes of Drugs | Baro ReceptorAntihypertensives | Classes of Drugs | Baro Receptor
Antihypertensives | Classes of Drugs | Baro ReceptorChetan Prakash
 
ANTI HYPERTENSIVE DRUG
ANTI HYPERTENSIVE DRUGANTI HYPERTENSIVE DRUG
ANTI HYPERTENSIVE DRUGAkshit Naveria
 
Cardiac Medications #4 08
Cardiac Medications #4 08Cardiac Medications #4 08
Cardiac Medications #4 08gerlam
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugsBONI RAFI
 
Anti hypertensive drugs
Anti hypertensive drugsAnti hypertensive drugs
Anti hypertensive drugsSyedSulaiman29
 
08 Antihypertensives Upd
08 Antihypertensives Upd08 Antihypertensives Upd
08 Antihypertensives UpdNurse Uragon
 
Antihypertensives acting on RAAS
Antihypertensives acting on RAASAntihypertensives acting on RAAS
Antihypertensives acting on RAASAnkita Bist
 
Drugsused in Cardiovascular System
Drugsused in Cardiovascular SystemDrugsused in Cardiovascular System
Drugsused in Cardiovascular Systemsarosem
 
Antihypertensive drug
Antihypertensive drugAntihypertensive drug
Antihypertensive drugShaikhSaniya2
 
Ch 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharmCh 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharmCMBurr43
 
anti hypertensive copy.pptx
anti hypertensive copy.pptxanti hypertensive copy.pptx
anti hypertensive copy.pptxKhaledEwais1
 
CONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPY
CONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPYCONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPY
CONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPYBobby Prashanth
 
drugs for the treatment ofheart Failure.pptx
drugs for  the treatment ofheart Failure.pptxdrugs for  the treatment ofheart Failure.pptx
drugs for the treatment ofheart Failure.pptxAdilZulfiqar7
 

Ähnlich wie Drug Classifications (20)

Drug Classifications
Drug ClassificationsDrug Classifications
Drug Classifications
 
NurseReview.Org - Antihypertensives Updates (pharmacology review notes)
NurseReview.Org - Antihypertensives Updates (pharmacology review notes)NurseReview.Org - Antihypertensives Updates (pharmacology review notes)
NurseReview.Org - Antihypertensives Updates (pharmacology review notes)
 
Antihypertensives
AntihypertensivesAntihypertensives
Antihypertensives
 
Ahtd4
Ahtd4Ahtd4
Ahtd4
 
Hypertension
HypertensionHypertension
Hypertension
 
A ntihypertensive drugs
A ntihypertensive drugsA ntihypertensive drugs
A ntihypertensive drugs
 
Antihypertensives | Classes of Drugs | Baro Receptor
Antihypertensives | Classes of Drugs | Baro ReceptorAntihypertensives | Classes of Drugs | Baro Receptor
Antihypertensives | Classes of Drugs | Baro Receptor
 
ANTI HYPERTENSIVE DRUG
ANTI HYPERTENSIVE DRUGANTI HYPERTENSIVE DRUG
ANTI HYPERTENSIVE DRUG
 
Cardiac Medications #4 08
Cardiac Medications #4 08Cardiac Medications #4 08
Cardiac Medications #4 08
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Anti hypertensive drugs
Anti hypertensive drugsAnti hypertensive drugs
Anti hypertensive drugs
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
08 Antihypertensives Upd
08 Antihypertensives Upd08 Antihypertensives Upd
08 Antihypertensives Upd
 
Antihypertensives acting on RAAS
Antihypertensives acting on RAASAntihypertensives acting on RAAS
Antihypertensives acting on RAAS
 
Drugsused in Cardiovascular System
Drugsused in Cardiovascular SystemDrugsused in Cardiovascular System
Drugsused in Cardiovascular System
 
Antihypertensive drug
Antihypertensive drugAntihypertensive drug
Antihypertensive drug
 
Ch 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharmCh 18 autonomic nervous system agents pharm
Ch 18 autonomic nervous system agents pharm
 
anti hypertensive copy.pptx
anti hypertensive copy.pptxanti hypertensive copy.pptx
anti hypertensive copy.pptx
 
CONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPY
CONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPYCONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPY
CONGESTIVE HEART FAILURE - DRUGS WITHOUT POSITIVE IONOTROPY
 
drugs for the treatment ofheart Failure.pptx
drugs for  the treatment ofheart Failure.pptxdrugs for  the treatment ofheart Failure.pptx
drugs for the treatment ofheart Failure.pptx
 

Mehr von Sherry Knowles

Mehr von Sherry Knowles (20)

CCRN Prep 2019 Pulmonary
CCRN Prep 2019 PulmonaryCCRN Prep 2019 Pulmonary
CCRN Prep 2019 Pulmonary
 
CCRN Prep 2019 Cardiovascular
CCRN Prep 2019 CardiovascularCCRN Prep 2019 Cardiovascular
CCRN Prep 2019 Cardiovascular
 
CCRN Review part 2
CCRN Review part 2CCRN Review part 2
CCRN Review part 2
 
CCRN Review part 1
CCRN Review part 1CCRN Review part 1
CCRN Review part 1
 
CCRN Review Part 2 (of 2)
CCRN Review Part 2 (of 2)CCRN Review Part 2 (of 2)
CCRN Review Part 2 (of 2)
 
CCRN Review Part 1 (of 2)
CCRN Review Part 1 (of 2)CCRN Review Part 1 (of 2)
CCRN Review Part 1 (of 2)
 
Advanced Hemodynamics
Advanced HemodynamicsAdvanced Hemodynamics
Advanced Hemodynamics
 
PCCN Review Part 2 (of 2)
PCCN Review Part 2 (of 2)PCCN Review Part 2 (of 2)
PCCN Review Part 2 (of 2)
 
PCCN Review Part 1 (of 2)
PCCN Review Part 1 (of 2)PCCN Review Part 1 (of 2)
PCCN Review Part 1 (of 2)
 
Rhythm Strip Review
Rhythm Strip ReviewRhythm Strip Review
Rhythm Strip Review
 
Levels Of Nursing Practice
Levels Of Nursing PracticeLevels Of Nursing Practice
Levels Of Nursing Practice
 
Heart Sounds And Murmurs
Heart Sounds And MurmursHeart Sounds And Murmurs
Heart Sounds And Murmurs
 
Hemodynamics
HemodynamicsHemodynamics
Hemodynamics
 
Blood Products
Blood ProductsBlood Products
Blood Products
 
Advanced Hemodynamics
Advanced HemodynamicsAdvanced Hemodynamics
Advanced Hemodynamics
 
Arterial Blood Gases
Arterial Blood GasesArterial Blood Gases
Arterial Blood Gases
 
Gastrointestinal Disorders
Gastrointestinal DisordersGastrointestinal Disorders
Gastrointestinal Disorders
 
C X R Interpretation
C X R  InterpretationC X R  Interpretation
C X R Interpretation
 
A D V A N C E D P A C I N G
A D V A N C E D  P A C I N GA D V A N C E D  P A C I N G
A D V A N C E D P A C I N G
 
Blood Products
Blood ProductsBlood Products
Blood Products
 

Kürzlich hochgeladen

Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...DhatriParmar
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsPooky Knightsmith
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1GloryAnnCastre1
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Projectjordimapav
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxMichelleTuguinay1
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQuiz Club NITW
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Developmentchesterberbo7
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptxmary850239
 
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxMan or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxDhatriParmar
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 

Kürzlich hochgeladen (20)

Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young minds
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Project
 
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptxDIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
DIFFERENT BASKETRY IN THE PHILIPPINES PPT.pptx
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
Faculty Profile prashantha K EEE dept Sri Sairam college of Engineering
Faculty Profile prashantha K EEE dept Sri Sairam college of EngineeringFaculty Profile prashantha K EEE dept Sri Sairam college of Engineering
Faculty Profile prashantha K EEE dept Sri Sairam college of Engineering
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Development
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx
 
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxMan or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
prashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Professionprashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Profession
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 

Drug Classifications

  • 1. Cardiac Drug Sherry L. Knowles, RN, CCRN, CRNI Classifications
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.

Hinweis der Redaktion

  1. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  2. DRUG CLASSIFICATION : In the Critical Care Unit 2004 Anti-thrombin Anti-platelet
  3. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  4. DRUG CLASSIFICATION : In the Critical Care Unit 2004 INOTROPIC Positive Inotropes Dopamine Digoxin Dobutamine Primacor Negative Inotropes Beta Blockers: Lopressor Calcium Channel Blockers: Verapamil
  5. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  6. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  7. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ALPHA BETA DOPA AGONISTS VS ANTAGONISTS ADRENERGIC VS BLOCKER
  8. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  9. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  10. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  11. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  12. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  13. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ACE INHIBITORS Enalapril (Vasotec) 2.5-20 mg bid Captopril (Capoten) 6.25-100 mg tid Lisinopril (Prinivil, Zestril) 5-40 mg qd Quinapril (Accupril) 5-20 mg bid Ramipril (Altace) 2.5-5 mg bid Fasinopril (Monopril) 20-40 mg qd SIDE EFFECTS: Dry Cough Hypotension Dizziness Headache Hyperkalemia Nausea Neutropenia Angioedema Cough, first-dose hypotension, hyperkalemia, renal failure, fetal injury, angioedema, rash, neutropenia, impaired taste WARNING: Do not give NSAIDS with Ace Inhibitors MUST REACH THERAPEAUTIC DOSAGE FOR BENEFITS. PRIL
  14. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ANGIOTENSIN II ANTAGONISTS Losartan Potassium (Cozar) 25-100 mg qd-bid Valsartan (Diovan) 160-320 mg qd SIDE EFFECTS: Better tolerated than ace inhibitors. Hypotension Dizziness Bradycardia Cramps Diarrhea Hyperkalemia Nausea Losartan (Cozaar) – does not cause angioedema or cough NO COUGH COMPARED TO ACE INHIBITORS
  15. DRUG CLASSIFICATION : In the Critical Care Unit 2004 Propranalol non-selective Esmolol 9 min. half-life (red cell esterases) Sotalol non-selective blocks K channels more effective for some arrhythmias BETA BLOCKERS Metoprolol (Lopressor, Toprol) Carvedilol (Coreg) 3.125-25 mg bid. Patients > 85 kg up to 50 mg bid Labetalol (Normodyne, Trandate) 200-400 mg bid Propranolol (Inderal) Esmolol (Brevibloc) Sotalol (Betapace) Naldolol (Corgard) Cardioselective: Atenolol (Tenormin) SIDE EFFECTS: Hypotension Dizziness AV Block Bradycardia Thrombocytopenia Elevated Liver Enzymes OLOL
  16. DRUG CLASSIFICATION : In the Critical Care Unit 2004 Propranalol non-selective Esmolol 9 min. half-life (red cell esterases) Sotalol non-selective blocks K channels more effective for some arrhythmias BETA BLOCKERS Metoprolol (Lopressor, Toprol) Carvedilol (Coreg) 3.125-25 mg bid. Patients > 85 kg up to 50 mg bid Labetalol (Normodyne, Trandate) 200-400 mg bid Propranolol (Inderal) Esmolol (Brevibloc) Sotalol (Betapace) Naldolol (Corgard) Cardioselective: Atenolol (Tenormin) SIDE EFFECTS: Hypotension Dizziness AV Block Bradycardia Thrombocytopenia Elevated Liver Enzymes OLOL
  17. DRUG CLASSIFICATION : In the Critical Care Unit 2004 NITRATES Nitroglycerin Isosorbide (Ismo, Imdur) SIDE EFFECTS: Hypotension Headache OTHER VASODILATORS: Nitroprusside (Nipride) Potent venous and arterial vasodilator. Used for hypertensive crisis. Hydralazine (Apresoline) 50-600 mg qd in divided doses bid-qid PERIPHERAL VASODILATORS: Nipride Hyperstat Apresoline Minoxidil CORONARY VASODILATORS: Imdur Isordil Nitro Persantine Do not combine with other drugs causing vasodilation (Viagra) or hypotensive drugs
  18. DRUG CLASSIFICATION : In the Critical Care Unit 2004 CALCIUM CHANNEL BLOCKERS Nifedipine (Procardia) Verapamil (Calan) Norvasc (Amlodipine)) Diltiazem (Cardizem) Prevent calcium from entering cells Used for hypertension, angina, cardiac dysrhythmias Calcium channels in vascular smooth muscle – when blocked – prevents contraction and therefore, vasodilation
  19. DRUG CLASSIFICATION : In the Critical Care Unit 2004 CALCIUM CHANNEL BLOCKERS Nifedipine (Procardia) Verapamil (Calan) Norvasc (Amlodipine)) Diltiazem (Cardizem)
  20. DRUG CLASSIFICATION : In the Critical Care Unit 2004 CALCIUM CHANNEL BLOCKERS Nifedipine (Procardia) Verapamil (Calan) Norvasc (Amlodipine)) Diltiazem (Cardizem)
  21. DRUG CLASSIFICATION : In the Critical Care Unit 2004 DIURETICS Furosemide (Lasix) 40-320 mg qd-bid Bumetanide (Bumex) 0.5 -10 mg qd, bid, tid, qod Ethacrynic Acid (Edecrin) 50-400 mg qd-bid Metolazone (Zaroxolyn) Torsemide (Demodex) HCTZ (Hydrochlorothiazide, HydroDIURIL) 50-200 mg qd May cause glucose intolerance and lipid abnormalities. POTASSIUM SPARING DIUTETICS: Spironolactone (Aldactone) 25-200 mg qd-tid Triamterene (Dyrenium 100-300 mg qd-bid Amiloride (Midamor) 5-20 mg qd SIDE EFFECTS: Hyponatremia Hypokalemia Ototoxicity Leukopenia Metabolic alkalosis Metabolic acidosis Mental confusion Nausea
  22. DRUG CLASSIFICATION : In the Critical Care Unit 2004 VASOPRESSORS Dopamine (10-20 mcg/kg/min Norepinephrine (Levophed) Epinephrine (Adrenalin) SYMPATHOMIMETICS
  23. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ANTIDYSRHYTHMICS Lidocaine Procainamide Amiodarone SIDE EFFECTS: AV Block Bradycardia QT Elongation
  24. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ANTIDYSRHYTHMICS Lidocaine Procainamide Amiodarone SIDE EFFECTS: AV Block Bradycardia QT Elongation
  25. DRUG CLASSIFICATION : In the Critical Care Unit 2004 Inhibits Platelet Activation ReoPro Integrilin Aggrastat Inhibits Platelet Receptor Sites Stops clotting activity at the site of the clot Can stop an MI
  26. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ADVERSE EFFECTS: Bleeding Thrombocytopenia – heparin induced Hypersensitivity Protamine sulfate for OD Monitoring of – APTT Given in units Low Molecular Heoparin: Enoxaparin - Lovenox Dalteparin Ardeparin COUMADIN: Long-term prophylaxis of thrombosis Prosthetic heart valves Atrial fibrillation Must monitor PT (prothrombin time) – INR (contains a correction factor for PT) PT/INR needs to be monitored frequently Vitamin K can be given in case of overdose Antiplatelet drugs: ASA – suppresses platelet aggregation Adenosine diphosphate receptor antagonists: Block ADP receptors preventing ADP-stimulated aggregation Ticlopidin – prevent stroke Clopidogrel – prevent stroke and MI ANTIDYSRHYTHMICS Lidocaine Procainamide Amiodarone SIDE EFFECTS: AV Block Bradycardia QT Elongation
  27. DRUG CLASSIFICATION : In the Critical Care Unit 2004 Heparin Induced Throbocytopenia
  28. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ANTIDYSRHYTHMICS Lidocaine Procainamide Amiodarone SIDE EFFECTS: AV Block Bradycardia QT Elongation
  29. DRUG CLASSIFICATION : In the Critical Care Unit 2004 ANTIDYSRHYTHMICS Lidocaine Procainamide Amiodarone SIDE EFFECTS: AV Block Bradycardia QT Elongation
  30. DRUG CLASSIFICATION : In the Critical Care Unit 2004 “ Statins” – HMG CoA inhibitors – most widely used – also increase number of LDL receptors on liver cells Lovastatin, Fluvastatin, Pravastatin, Simvastatin, Atorvastatin, Cerivastatin Adverse Effects: Hepatotoxicity, GI disturbances, myopathy ANTI-LIPIDEMICS Lopid (Gemfibrozil) Mevacor (Lovastatin) Zocor (Simvastatin) Provachol (Pravastatin) Questran (Cholestyramine)
  31. DRUG CLASSIFICATION : In the Critical Care Unit 2004
  32. DRUG CLASSIFICATION : In the Critical Care Unit 2004 Long half-life Bad side effects – pulmonary toxicity Bluish discoloration of skin GI side effects Liver dysfunction Thyroid dysfunction
  33. DRUG CLASSIFICATION : In the Critical Care Unit 2004 DIGOXIN USES: CHF ATRIAL FIB/FLUTTER PAT DOSAGE:  0.125-0.5 mg qd  May be diluted in 5-10 cc NS or D 5 W  Given slowly IV (over 5 minutes) diluted in 5-10 cc. NURSING IMPLICATIONS:  Maintain potassium in normal range.  Monitor digoxin and electrolyte levels.  Use cautiously with the elderly, acute MI’s, severe pulmonary disease, advanced heart failure, hypothyroidism, and renal insufficiency.  Monitor for Adverse Effects: (ST depression, PVC’s, bradycardia, blocks, or other dysrhythmias, headache, weakness, agitation, apathy, nausea, yellow-green halos around images, or blurred vision)  May hold for low heart rate. Digoxin Inhibit Na/K ATPase Not SR Ca pump Decreased Na gradient less Ca extrusion across plasma membrane more Ca pumped into SR Positive inotropic effects Digitalis Glycosides: Adverse Effects: Digitalis intoxication is a common clinical problem Digitalis intoxication arrhythmias Nausea Disturbances of cognitive function Competes with potassium for binding – when potassium is low, Digoxin is high Therapeutic Range: Important to know - .5-2.0ng/ml But patient may be “toxic” even if within the normal range Measures to treat toxicity – pacemaker, antidysrhythmics, digibind Adverse Effects: DYSRHYTHMIAS TOXICITY – very narrow therapeutic index – hypokalemia makes it easier for toxicity to occur GI – disturbances Fatigue Visual disturbances
  34. DRUG CLASSIFICATION : In the Critical Care Unit 2004 DOPAMINE USES:  Hypotension (without Hypovolemia)  Cardiogenic Shock  Severe CHF  To improve renal perfusion (low dose) ACTIONS:  Renal. mesenteric, and cerebral vasodilation (low dose).   cardiac output (moderate dose).  Potent vasoconstrictor (high dose). NURSING IMPLICATIONS:  Titrate to effect/Assess VS frequently.  Watch for Adverse Effects: (Tachycardia, hypertension, vasoconstriction (loss of renal or mesenteric perfusion), extension of an MI, tissue necrosis, etc.).  May cause ectopy
  35. DRUG CLASSIFICATION : In the Critical Care Unit 2004 DODUTAMINE USES: CHF Pulmonary Congestion Low Cardiac Output ACTIONS:   Contractility   Afterload (  SVR)   Preload DOSE: 3-5 mcg/kg/min  May cause ectopy
  36. DRUG CLASSIFICATION : In the Critical Care Unit 2004 PRIMACOR (Milrinone) USES: CHF ACTIONS: *  Contractility *  Afterload *  Preload NURSING IMPLICATIONS: * Incompatible with Lasix * Contraindicated in IHSS * Must use cautiously with Renal Insufficiency. * Monitor for Adverse Effects (Dysrhythmias, Hypotension, etc.) LOADING DOSE: 50 mcg/kg over 10 minutes MAINTENANCE DOSE: 0.375-0.75 mcg/kg/min INOCOR (Amrinone)
  37. DRUG CLASSIFICATION : In the Critical Care Unit 2004 EPINEPHRINE USES: Asystole/-fib Severe Hypotension Anaphylaxis Acute Bronchospasm ACTIONS: Peripheral Vasoconstriction NURSING IMPLICATIONS:  Available in two concentrations (1:1000 and 1:10,000)  Contraindicated in hypovolemia.  Monitor for Adverse Effects (V-tach, V-Fib, Tachycardia, Vasoconstrictor.)
  38. DRUG CLASSIFICATION : In the Critical Care Unit 2004 LEVOPHED
  39. DRUG CLASSIFICATION : In the Critical Care Unit 2004 NEO-SYNEPHRINE USES: Severe Hypotension Shock Drug Induced Hypotension PSVT ACTIONS: Vasoconstriction NURSING IMPLICATIONS:  Enhances effects of Isuprel, Aminophylline, and Atropine.  Monitor for Adverse Effects (Tachycardia, Bradycardia, Ectopy, Angina, Respiratory Depression, Tissue Necrosis, etc.)
  40. DRUG CLASSIFICATION : In the Critical Care Unit 2004 NITROGLYCERIN USES: Angina AMI Myocardial Ischemia CHF HTN Heart Failure ACTIONS:   Preload (Primarily dilates venous system)   Myocardial Ischemia (dilates coronary arteries)   SVR  Helps Prevent Coronary Artery Vasospasm. NURSING IMPLICATIONS:  Assess for desired effects.  Monitor for Adverse Effects (Hypotension, Headache, Dizziness, Flushing)
  41. DRUG CLASSIFICATION : In the Critical Care Unit 2004 MORPHINE USES: Pain Dyspnea (due to pulmonary congestion) ACTIONS:   Preload   Pulmonary Congestion  Cough Suppressant NURSING IMPLICATIONS:  Assess for desired effects  Have Narcan Available  Monitor for Adverse Effects (Hypotension, Respiratory Depression, N/V, etc.)
  42. DRUG CLASSIFICATION : In the Critical Care Unit 2004 OTHER CARDIAC DRUGS ANTI COAGULANTS Heparin Lovenox Coumadin TPA Eminase Strepto Urokinase Amicar ANTI PLATELET ASA Ticlid Persantine ReoPro Aggrastat Integrin